TCMBANKGE000053 |
NFKB1 |
CVID12; EBP-1; KBF1; NF-kB; NF-kB1; NF-kappa-B1; NF-kappaB; NF-kappabeta; NFKB-p105; NFKB-p50; NFkappaB |
nuclear factor kappa B subunit 1 |
TCMBANKGE000241 |
CASP8 |
ALPS2B; CAP4; Casp-8; FLICE; MACH; MCH5 |
caspase 8 |
TCMBANKGE000294 |
CDKN1A |
CAP20; CDKN1; CIP1; MDA-6; P21; SDI1; WAF1; p21CIP1 |
cyclin dependent kinase inhibitor 1A |
TCMBANKGE000665 |
CASP6 |
MCH2 |
caspase 6 |
TCMBANKGE000697 |
APAF1 |
APAF-1; CED4 |
apoptotic peptidase activating factor 1 |
TCMBANKGE000715 |
BID |
FP497 |
BH3 interacting domain death agonist |
TCMBANKGE000925 |
PCNA |
ATLD2 |
proliferating cell nuclear antigen |
TCMBANKGE000933 |
IKBKB |
IKK-beta; IKK2; IKKB; IMD15; IMD15A; IMD15B; NFKBIKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
TCMBANKGE000968 |
CYCS |
CYC; HCS; THC4 |
cytochrome c, somatic |
TCMBANKGE001013 |
BIRC5 |
API4; EPR-1 |
baculoviral IAP repeat containing 5 |
TCMBANKGE001045 |
CCND1 |
BCL1; D11S287E; PRAD1; U21B31 |
cyclin D1 |
TCMBANKGE001098 |
NFKBIA |
EDAID2; IKBA; MAD-3; NFKBI |
NFKB inhibitor alpha |
TCMBANKGE001130 |
BAD |
BBC2; BCL2L8 |
BCL2 associated agonist of cell death |
TCMBANKGE001131 |
CASP9 |
APAF-3; APAF3; ICE-LAP6; MCH6; PPP1R56 |
caspase 9 |
TCMBANKGE001132 |
BAX |
BCL2L4 |
BCL2 associated X, apoptosis regulator |
TCMBANKGE001156 |
CASP3 |
CPP32; CPP32B; SCA-1 |
caspase 3 |
TCMBANKGE001166 |
BCL2 |
Bcl-2; PPP1R50 |
BCL2 apoptosis regulator |
TCMBANKGE001169 |
BCL2L1 |
BCL-XL/S; BCL2L; BCLX; Bcl-X; PPP1R52 |
BCL2 like 1 |
TCMBANKGE001177 |
TP53 |
BCC7; BMFS5; LFS1; P53; TRP53 |
tumor protein p53 |
TCMBANKGE001184 |
RELA |
CMCU; NFKB3; p65 |
RELA proto-oncogene, NF-kB subunit |